Khelfa Yousef, Mansour Munthir, Abdel-Aziz Yousef, Raufi Ali, Denning Krista, Lebowicz Yehuda
Marshall University, Huntington, WV, USA.
J Investig Med High Impact Case Rep. 2016 Nov 4;4(4):2324709616674742. doi: 10.1177/2324709616674742. eCollection 2016 Oct-Dec.
Acinic cell carcinoma (ACC) is an uncommon salivary gland neoplasm that generally displays an indolent growth pattern. Most cases arise in the major glands, particularly the parotid. However, it can arise from minor salivary glands in the oral cavity and aero-digestive tract. Although ACC is generally a low-grade malignant tumor, poorly differentiated and high-grade transformed variants exhibit a propensity for late recurrence and metastasis. There are no adequate clinical trials that define the optimal approach to patients with metastatic salivary gland tumors due to its rarity. Systemic therapy is reserved for cases where local therapy, such as radiation or metastasectomy, is not appropriate. Nevertheless, there is insufficient data in the literature regarding the chemotherapy of choice for metastatic ACC. In this article, we report a case of metastatic ACC of the right parotid gland that progressed on carboplatin and paclitaxel after partial response followed by doxorubicin and is currently on checkpoint inhibitor treatment.
腺泡细胞癌(ACC)是一种罕见的唾液腺肿瘤,通常表现为惰性生长模式。大多数病例发生于大唾液腺,尤其是腮腺。然而,它也可起源于口腔和气道消化道的小唾液腺。尽管ACC一般是低级别恶性肿瘤,但低分化和高级别转化的变体有晚期复发和转移的倾向。由于其罕见性,尚无足够的临床试验来确定转移性唾液腺肿瘤患者的最佳治疗方法。全身治疗适用于局部治疗(如放疗或转移灶切除术)不合适的病例。然而,文献中关于转移性ACC的首选化疗的数据不足。在本文中,我们报告了一例右腮腺转移性ACC病例,该病例在部分缓解后接受卡铂和紫杉醇治疗病情进展,随后接受阿霉素治疗,目前正在接受检查点抑制剂治疗。